Floatz logo

Romidepsin

Myelofibrosis

Center for International Blood and Marrow Transplant ResearchSmall moleculePhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
73/ 100

Competitive context

47 Active assets in the Myelofibrosis cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
City of Hope Medical Center
Phase 3B
CYCLOSPORIN A
City of Hope Medical Center
Phase 2B
Busulphan
City of Hope Medical Center
Phase 2B
FILGRASTIM
City of Hope Medical Center
Phase 3B
Anti-Thymoglobulin, Rabbit
Fred Hutchinson Cancer Center
Phase 2/3B

View all 50 →

Same molecule, other indications

Romidepsin is also rated in:

Myelodysplastic/Myeloproliferative DiseasesDormant
BBB
Indicative ·
76 / 100
View asset →
Recurrent Mycosis Fungoides/Sezary SyndromeDormant
BBB
Indicative ·
75 / 100
View asset →
Multiple Myeloma and Plasma Cell NeoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →